Molecular Surgeon Symposium on Pancreatic Cancer

描述（由申请人提供）：分子外科医生研讨会将汇集活跃的研究人员在选定的科学领域的定义和分析重要的科学问题和互动环境中的最新进展的目的。 2003年胰腺癌分子外科医生研讨会将于2003年6月在德克萨斯州休斯顿的贝勒医学院举行。 本次研讨会是为数不多的提供了一个论坛，介绍和讨论广泛的最新分子进展的胰腺癌研究。 2003年的专题讨论会将包括一个开幕主旨发言和以下科学会议：1）。转录因子、细胞增殖、迁移和凋亡; 2）.生长因子、激素、受体、信号转导途径-I; 3）。生长因子、激素、受体、信号转导途径-II; 4）。基因和分子标记-I; 5）.基因和分子标记-II; 6）.疫苗，基因和分子治疗，最后7）。从实验室到临床的胰腺癌研究总结。 所有与会者将被邀请提交一份摘要到研讨会的海报部分，让所有与会者，特别是学生，外科住院医生，博士后研究员和年轻的研究人员，展示数据并充分参与讨论。 本次研讨会将汇集一批不同的学术科学家，他们的兴趣范围从研究胰腺癌发病机制的分子机制的基础研究人员，到对分子疗法和了解胰腺疾病感兴趣的医生科学家。 有限的出席人数，重点科学会议，以及非常成功的海报会议联合收割机结合起来，为思想交流提供了一个令人兴奋的论坛，并为对胰腺癌感兴趣的不同科学家群体提供了广泛的参与机会。 在研讨会结束时，与会者应能够：1）了解分子生物学技术对胰腺癌研究的影响; 2）讨论与胰腺癌分子发病机制，诊断和治疗相关的最新科学进展; 3）确定胰腺癌研究的未来方向;以及4）建立胰腺癌研究的合作网络。 所有讲座将被录像，并在我们的“分子外科医生”网站上提供给公众访问。 本网站自1999年第一次研讨会以来一直在建立。

DESCRIPTION (provided by applicant): The Molecular Surgeon Symposium will bring together active researchers in a selected scientific field with the purpose of defining and analyzing important scientific problems and recent advances in an interactive environment. The 2003 Molecular Surgeon Symposium on Pancreatic Cancer will be held at the Baylor college of Medicine, Houston, Texas, in June 2003. This symposium is one of the few that provides a forum for presentation and discussion of a broad spectrum of the latest molecular advances in pancreatic cancer research. The 2003 symposium will consist of an opening keynote presentation with the following scientific sessions: 1). Transcription factors, cell proliferation, migration, and apoptosis; 2). Growth factors, hormones, receptors, signal transduction pathways-I; 3). Growth factors, hormones, receptors, signal transduction pathways-II; 4). Genes, and molecular markers-I; 5). Genes, and molecular markers-II; 6). Vaccine, gene and molecular therapy, and finally 7). Closing remarks on the pancreatic cancer research-from bench to bedside. All meeting participants will be invited to submit an abstract to the poster section planned for the symposium that allows all attendees, especially students, surgical residents, postdoctoral fellows, and young investigators, to present data and fully participate in discussions. This symposium will bring together a diverse group of academic scientists with interests ranging from basic researchers studying molecular mechanisms of pancreatic cancer pathogenesis, to physician-scientists interested in molecular therapies and in understanding pancreatic diseases. The limited attendance, focused scientific sessions, and highly successful poster session combine to provide an exciting forum for the exchange of ideas and to provide extensive opportunities for participation by a diverse group of scientists interested in pancreatic cancer. At the conclusion of the symposium, participants should be able to: 1) understand the impact of molecular biology technology for pancreatic cancer research; 2) discuss recent scientific advances related to molecular pathogenesis, diagnosis, and therapy for pancreatic cancer; 3) determine the future directions of pancreatic cancer research; and 4) establish collaboration network of pancreatic cancer research. All talks will be video-taped and presented at our "The Molecular Surgeon" website for general public access. This website has been established since first symposium in 1999.